Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

n-3 polyunsaturated fatty acids: update 1995

S Endres1, R De Caterina, E B Schmidt

  • 1Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Munich, Germany.

European Journal of Clinical Investigation
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registry.

European journal of internal medicine·2026
Same author

Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.

International journal of cardiology·2026
Same author

Incidence of seropositive and seronegative rheumatoid arthritis in Denmark: a nationwide population-based study.

Scandinavian journal of rheumatology·2024
Same author

Newly diagnosed with inflammatory arthritis (NISMA)-development of a complex self-management intervention.

BMC health services research·2023
Same author

Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study.

Scandinavian journal of rheumatology·2021
Same author

Randomized clinical trial on closure versus non-closure of mesenteric defects during laparoscopic gastric bypass surgery.

The British journal of surgery·2021
Same journal

Pacemaker Status and 5-Year Mortality After TAVI: A Sex-Specific Analysis.

European journal of clinical investigation·2026
Same journal

Causal Effects of Time-Varying Treatments: The G-Formula.

European journal of clinical investigation·2026
Same journal

Improving Scientific Research: Renegotiated Principles of Science, Proposals, Failures, and Successes.

European journal of clinical investigation·2026
Same journal

Beta-Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta-Analysis With Trial Sequential Analysis.

European journal of clinical investigation·2026
Same journal

Prognostic Role of Serum Albumin Levels in Elderly Patients With Non-Valvular Atrial Fibrillation.

European journal of clinical investigation·2026
Same journal

Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

European journal of clinical investigation·2026
See all related articles

Omega-3 fatty acids show varied effects in clinical trials. While some conditions like IgA-nephropathy and kidney transplant recovery show benefits, others like rheumatoid arthritis and lupus nephritis have moderate or negative outcomes.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Nephrology

Background:

  • Epidemiologic and biochemical studies suggest n-3 fatty acids possess anti-inflammatory properties.
  • Previous small-group studies indicated potential therapeutic benefits, necessitating validation in larger trials.
  • A growing body of clinical trials investigates n-3 fatty acid supplementation across various diseases.

Purpose of the Study:

  • To evaluate the efficacy of n-3 fatty acid supplementation in diverse clinical conditions.
  • To confirm or refute previously suggested therapeutic benefits in controlled, large-cohort studies.
  • To assess the impact of n-3 fatty acids on inflammatory and autoimmune diseases.

Main Methods:

  • Analysis of data from completed large-cohort controlled clinical trials.

Related Experiment Videos

  • Meta-analysis of existing studies on n-3 fatty acid supplementation.
  • Inclusion of patient groups with rheumatoid arthritis, arterial hypertension, lupus nephritis, psoriasis, atopic dermatitis, coronary artery disease, IgA-nephropathy, and kidney transplantation.

    • Main Results:

    • Moderate clinical benefits observed in patients with rheumatoid arthritis and arterial hypertension.
    • Negative results reported for lupus nephritis, psoriasis, and atopic dermatitis.
    • Inconclusive results for coronary artery disease post-angioplasty, contradicting earlier meta-analyses.
    • Clear benefits demonstrated in patients with IgA-nephropathy and kidney transplant recipients receiving fish oil.

    Conclusions:

    • The therapeutic effects of n-3 fatty acids are condition-specific, with notable benefits in certain kidney diseases.
    • Further phase III clinical trials are warranted to explore promising results in IgA-nephropathy and kidney transplantation.
    • Overall clinical benefits of n-3 fatty acids are not universally established and require careful patient selection.